The

drugs

industry closed the day down 1.4%.

ProPhase Labs Inc

(

PRPH

),

Neptune Technologies & Bioressources Inc

(

NEPT

),

Marina Biotech Inc

(

MRNA

), and

Agenus Inc

(

AGEN

) were all decliners today within the drugs industry with

Valeant Pharmaceuticals International Inc

(

VRX

) being today's featured drugs loser. Valeant Pharmaceuticals International Inc fell 37 cents (-1%) to $37.11 on average volume. Throughout the day, 2.7 million shares of Valeant Pharmaceuticals International Inc exchanged hands as compared to its average daily volume of 3.3 million shares.

Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, develops, manufactures, and markets pharmaceutical products in the areas of neurology, dermatology, and branded generics. Its product portfolio comprises approximately 490 products. Valeant Pharmaceuticals International Inc has a market cap of $11.6 billion and is part of the

health care

sector. Shares are up 32.5% year to date as of the close of trading on Thursday.

TheStreet Ratings rates Valeant Pharmaceuticals International as a

hold

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and increase in net income. However, as a counter to these strengths, we find that the growth in the company's earnings per share has not been good.

On the positive front,

Aoxing Pharmaceutical Company Inc

(

AXN

),

Acura Pharmaceuticals Inc

(

ACUR

),

Medgenics Inc

(

MDGN

), and

YM Biosciences Inc

(

YMI

) were all gainers within the drugs industry with

Bristol-Myers Squibb Company

(

BMY

) being today's featured drugs industry winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the drugs industry could consider

SPDR S&P Pharmaceuticals ETF

(

XPH

) while those bearish on the drugs industry could consider

ProShares UltraShort Nasdaq Biotech

(

BIS

).

null